|
|
|
| miR-145-5p Influences the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Regulating PHB2 |
| LI Xinjun, ZHONG Minhua, WU Zhanling, et al |
| Xiaogan Central Hospital, Hubei Xiaogan 432000, China |
|
|
|
|
Abstract Objective: To explore the role and mechanism of miR-145-5p in regulating the proliferation and migration of non-small cell lung cancer cells by targeting PHB2. Methods: The expression of miR-145-5p in NSCLC tissues and adjacent tissues, normal human bronchial epithelial cell line (BEAS-2B), and non-small cell lung cancer cell line (A549) was assessed by RT-PCR. The effect of miR-145-5p overexpression on NSCLC activity was determined by MTT and EDU. The effect of miR-145-5p overexpression on migration and invasion of NSCLC was evaluated by scratch test and Transwell. The luciferase reporter assay confirmed the role of miR-145-5p in the 3' -untranslated region (3'-UTR) of the PHB2 protein coding gene PHB2 mRNA. The expression of PHB2 protein in A549 cells was detected by western blot.A549 cells were transfected with pcDNA-phB2 and the levels of cell proliferation, migration and invasion were assessed. Results: The expression of miR-145-5p in NSCLC was significantly lower than that in paracancerous tissues (P<0.01), which was about 47.54±10.12% of paracancerous tissues. After transfection with miR-145-5p mimic, the proliferation, migration and invasion of tumor cells were significantly inhibited in vitro (P<0.001), which were about 28.31±13.97%, 30.57±5.84% and 32.56±6.99% of those in the control group, respectively. miR-145-5p negatively regulates the expression of PHB2 by directly binding the 3'-UTR of PHB2 mRNA. After co-transfection with miR-145-5p and PHB2, the proliferation, migration and invasion ability of A549 cells were significantly enhanced compared with that of miR-145-5p group alone. Conclusion: MiR-506-3p inhibitions the proliferation, migration and invasion of non-small cell lung cancer cells by targeting PHB2 mRNA, and may be a promising therapeutic direction in anti-cancer therapy.
|
|
|
|
|
|
[1] Feng RM,Zong YN,Cao SM,et al.Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics[J].Cancer Commun (Lond),2019,39(1):22.
[2] Sayan M,Satir Turk M,Celik A,et al.Surgical outcomes of early-stage small-cell lung cancer:single-center experience[J].Asian Cardiovasc Thorac Ann,2019,27(3):187~191.
[3] Li G,Shi H,Wang X,et al.Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma[J].Mol Med Rep,2019,20(2):1121~1130.
[4] Huang C,Tang S,Shen D,et al.Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma[J].Oncol Lett,2021,21(2):168.
[5] Li M,Yu D,Li Z,et al.Long non-coding RNA AFAP1AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR 145/HOXA1 axis[J].Oncol Rep,2021,45(3):1094~1104.
[6] Hill M,Tran N.MicroRNAs Regulating MicroRNAs in Cancer[J].Trends Cancer,2018,4(7):465~468.
[7] Li ZY,Zhang ZZ,Bi H,et al.MicroRNA 4500 suppresses tumor progression in non small cell lung cancer by regulating STAT3[J].Mol Med Rep,2019,20(6):4973~4983.
[8] Zhang J,Yan YG,Wang C,et al.MicroRNAs in osteosarcoma[J].Clin Chim Acta,2015,444:9~17.
[9] 兰天,刘巍梦,邹阳,等.miR-145-5p靶向TPM3通过ERK信号通路抑制甲状腺癌TPC-1细胞侵袭和转移[J].中国医药生物技术,2021,16(1):18~26.
[10] Zhu Z,Wu Q,Zhang M,et al.Hsa_circ_0016760 exacerbates the malignant development of non small cell lung cancer by sponging miR 145 5p/FGF5[J].Oncol Rep,2021,45(2):501~512.
[11] Wu B,Chang N,Xi H,et al.PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer[J].Theranostics,2021,11(7):3150~3166.
[12] Xiang X,Fu Y,Zhao K,et al.Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2[J].Theranostics,2021,11(10):4929~4944. |
|
|
|
2021, Vol. 27 
